Half a year after being spurned by the FDA and following deep layoffs, IO Biotech has decided to close its doors for good, Fierce Biotech reported. The Danish biotech has ceased operations and said goodbye to its employees, C-suite and board of directors after filing for bankruptcy, according to a March 31 filing with the Securities and Exchange Commission. A trustee appointed by the Delaware bankruptcy court will take control of the company and liquidate its assets.
Orbex’s Danish subsidiary, Orbital Express Launch ApS, is set to file for bankruptcy, with its facilities officially closing on 20 January and approximately 90 employees losing their jobs, European Spaceflight reported. U.K.-based Orbital Express Launch (Orbex) established its business in Denmark in October 2016. According to the company, its Copenhagen-based business carried out work in propulsion, testing, software, avionics and business services.